Masters of Longevity - The Pulse

PR Newswire18 Jun 2026
AIAI-Powered Analysis by HistoIndex Reveals Robust Liver Fibrosis Improvement with D&D Pharmatech (PR Newswire)

AI-Powered Analysis by HistoIndex Reveals Robust Liver Fibrosis Improvement with D&D Pharmatech

Read how AI-driven quantitative pathology corroborated histological fibrosis improvements in a metabolic-related steatohepatitis trial and strengthened efficacy readouts.

Key takeaways
  • AI qFibrosis analysis assessed 27 protocol-compliant liver biopsies from the trial.
  • Treated patients achieved ≥1-stage fibrosis improvement in 81.8% versus 18.8% placebo.
  • Steatosis-corrected qFibrosis scores fell −41.0% with treatment versus +9.5% placebo.
Longevity Technology18 Jun 2026
AIProJenX completes enrollment for Phase 1b trial of ALS drug Prosetin (Longevity Technology)

ProJenX completes enrollment for Phase 1b trial of ALS drug Prosetin

A clinical update on an ALS therapeutic's ongoing trial, covering interim data, biomarker analyses, and upcoming scientific presentations.

Key takeaways
  • Phase 1b study completed enrollment with 41 participants across five dose levels.
  • Treatment showed an exposure-related decrease in phosphorylated MAP2K4 in PBMCs.
  • Plasma concentrations at the two highest doses reached the preclinical therapeutic exposure range.
Frontiers - Health18 Jun 2026
AIEditorial: Fermented foods in modern nutrition: exploring health benefits and research innovations (Frontiers - Health)

Editorial: Fermented foods in modern nutrition: exploring health benefits and research innovations

Survey of recent research and innovations in fermented foods, covering health impacts, functional ingredients, and industrial challenges.

Key takeaways
  • Fermented bamboo shoots reduced TNF-α, IL-1β, and IL-6 in ulcerative colitis models.
  • Fermented broccoli stem by-products reduced weight gain and improved metabolic markers in obese mice.
  • Tempeh flour exhibited higher cholesterol-binding and lipase inhibitory activities than soybean flour.
Longevity Technology18 Jun 2026
AIQihan Biotech cell therapy makes history with three expedited FDA designations (Longevity Technology)

Qihan Biotech cell therapy makes history with three expedited FDA designations

Examine an off-the-shelf dual-target allogeneic CAR-T therapy securing top expedited regulatory pathways and implications for off-the-shelf cell therapy development.

Key takeaways
  • Awards follow a Fast Track designation granted in November 2025.
  • We are open to conversations with prospective partners and investors who share our vision.
  • Hangzhou Qihan Biotech announced that its off-the-shelf.
MoL Event Pick
The Longevity Show 2026 (London, United Kingdom)

The Longevity Show 2026

26. JUN 2026 - 27. JUN 2026 - London, United KingdomExpo

The UK’s first longevity festival, helping you discover what really works for living healthier, longer. Testing, workouts, speakers & more.